Summary
Overview
Work History
Education
Skills
Languages
Timeline
Generic

Hana Prokopcova

Vosselaar

Summary

Multi-talented Associate Director applies [Number] years of experience in [Type] operations. Manages diverse business areas with eye for efficiency and quality. Excellent team leader and analytical problem-solver.

Overview

13
13
years of professional experience

Work History

Associate Director

Center of Excellence for Predictive Analytics and Stability Sciences, Therapeutics Development & Supply, Johnson & Johnson Innovative Medicine
Belgium
12.2019 - Current
  • Responsible for defining and implementing the overall strategy for the Center of Excellence, including staffing and budgeting
  • Managing a team of PhD-level scientists focused on utilizing scientific, in-silico, and data-based approaches to assess drug stability and reactivity, supporting drug discovery, development, and commercial organization
  • Spearheaded the development and adaptation of state-of-the-art modeling tools, processes, and technologies, driving innovation and operational excellence within the organization while managing cross-portfolio support
  • Built and Expanded a High-Performance Team from four specialists to nine members by leveraging new scientific and modeling opportunities within and beyond the Therapeutics Development & Supply - Synthetics (TDS Synthetics) organization
  • Expanded team expertise to encompass first-principle computational chemistry and data-driven physics-based modeling
  • Impact and Recognition: In 2023, the team achieved notable awards, including a Vice President R&D Award, an Innovation Leadership Award, and 27 Inspire Awards with full team recognition, secured 2 patent co-inventorships and published 3 scientific papers with significant impact
  • Lab Management: Oversee a drug degradation chemistry lab with 3 BPO technicians and 1-2 postdoctoral researchers, ensuring operational excellence and innovation
  • Strategic Collaborations: Fostered strong partnerships with pharmaceutical companies, research centers, and universities, driving sector-wide innovation, served on the organizing committee for the Science of Stability Conference, focusing on cutting-edge advancements in predictive stability
  • Lead of In-Silico Formulation Design Initiative (March 2024 - present) – a one-year assignment in Pharmaceutical Product Development & Supply (PPDS), focused on reimagining formulation design by identifying and leveraging modeling opportunities to enhance and accelerate formulation design cycles
  • Decision Support Lead Function (2019-2020) – a two-year assignment as a member of the senior leadership team of TDS Synthetics as part of a leadership development program. Led communication efforts within the TDS Synthetics department, established and managed the Yammer platform, and facilitated change leadership. Successfully managed a global reorganization project from conceptualization to execution.

Senior Scientist Stability Expert

Clinical Release and Stability, Therapeutics Development & Supply, Johnson & Johnson Innovative Medicine
Belgium
02.2016 - 11.2019
  • Scientific Lead of the Risk-Based Predictive Stability (RiBPS) program, an innovative initiative that integrates accelerated stability studies with advanced statistical modeling to accurately predict long-term product stability and prevent late-stage drug stability failures
  • Oversaw the enrollment of RiBPS studies for the synthetics portfolio and developed filing strategies using accelerated stability data
  • Coached a team of 14 project managers in stability science
  • Led internal and external initiatives to develop cutting-edge software for predictive stability studies
  • Represented J&J in international consortiums and collaborations focused on Risk-Based Predictive Stability and trained the ICH community of regulators on stability guidelines and predictive stability methodologies.

Senior Scientist and Group Leader

API Small Molecule Development, Therapeutics Development & Supply, Johnson & Johnson Innovative Medicine
Belgium
04.2015 - 02.2016
  • Scientific lead and manager of a group of 12 project analysts supporting the small molecule API development department, overseeing approximately 20 development projects, including post-approval support under non-GMP and GMP conditions and crisis investigations in the production environment
  • Successfully led the scientific transformation of the team, including strategic hires
  • Restructured the team to leverage individual talents, enhancing overall productivity
  • Introduced new innovation capabilities and expanded outsourcing capacity.

Scientist

API Small Molecules Development Research & Development, Therapeutics Development & Supply, Johnson & Johnson Innovative Medicine
Belgium
09.2013 - 04.2015
  • Responsible for scientific support of the project analysts' group and served as project analyst for several portfolio projects
  • Led scientific meetings to share lessons learned, evaluate potential improvements, and discuss new trends in analytics
  • Introduced MS technology, providing team training and successfully integrating it into portfolio support
  • Implemented genotoxic analysis within the department and collaborated with industrial partners to achieve state-of-the-art genotoxic assessment and analysis.

Medicinal Chemist

Discovery CNS Medicinal Chemistry Research & Development, Janssen - Therapeutics Development & Supply, Johnson & Johnson Innovative Medicine
Belgium
04.2011 - 09.2013
  • Responsible for designing and synthesizing novel chemotypes for BACE1 inhibitors as potential lead compounds, conducting multistep synthesis from milligram to gram scale, and supporting analysis
  • Supervised master students in their synthetic work and thesis.

Education

Ph.D. -

University of Antwerp
Antwerp, Belgium

Skills

  • Strategic leadership
  • Critical Thinking

Languages

Slovak
First Language

Timeline

Associate Director

Center of Excellence for Predictive Analytics and Stability Sciences, Therapeutics Development & Supply, Johnson & Johnson Innovative Medicine
12.2019 - Current

Senior Scientist Stability Expert

Clinical Release and Stability, Therapeutics Development & Supply, Johnson & Johnson Innovative Medicine
02.2016 - 11.2019

Senior Scientist and Group Leader

API Small Molecule Development, Therapeutics Development & Supply, Johnson & Johnson Innovative Medicine
04.2015 - 02.2016

Scientist

API Small Molecules Development Research & Development, Therapeutics Development & Supply, Johnson & Johnson Innovative Medicine
09.2013 - 04.2015

Medicinal Chemist

Discovery CNS Medicinal Chemistry Research & Development, Janssen - Therapeutics Development & Supply, Johnson & Johnson Innovative Medicine
04.2011 - 09.2013

Ph.D. -

University of Antwerp

Similar Profiles

CREATE PROFILE
Hana Prokopcova